Cargando…

Effects of ginsenoside compound K on colitis-associated colorectal cancer and gut microbiota profiles in mice

BACKGROUND: Ginsenoside compound K (GC-K), generated from ginseng saponins bioconverted by gut microbiota, has potential anti-colorectal cancer (CRC) effects. Meanwhile, GC-K may interact with gut microbiota, playing important roles in the occurrence and development of CRC. However, the effects of g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Li, Guo, Yin-Ping, Wang, Li, Chen, Man-Yun, Zhang, Wei, Deng, Sheng, Huang, Wei-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073768/ https://www.ncbi.nlm.nih.gov/pubmed/35530961 http://dx.doi.org/10.21037/atm-22-793

Ejemplares similares

Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota
por: Wang, Li, et al.
Publicado: (2022)

Bioconversion variation of ginsenoside CK mediated by human gut microbiota from healthy volunteers and colorectal cancer patients
por: Guo, Yin-Ping, et al.
Publicado: (2021)

Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K
por: Hasebe, Takumu, et al.
Publicado: (2016)

Comparative Analysis of the Gut Microbiota in People with Different Levels of Ginsenoside Rb1 Degradation to Compound K
por: Kim, Kyung-Ah, et al.
Publicado: (2013)

Gut Microbiota Modulates the Protective Role of Ginsenoside Compound K Against Sodium Valproate-Induced Hepatotoxicity in Rat
por: Zhou, Luping, et al.
Publicado: (2022)

Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism
por: Cheng, Hao, et al.
Publicado: (2022)

Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
por: Zhuang, Tongxi, et al.
Publicado: (2021)

A narrative review of the pharmacology of ginsenoside compound K
por: Liu, Tao, et al.
Publicado: (2022)

Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs
por: Kuang, Yun-Yan, et al.
Publicado: (2021)

Genome-scale CRISPR screening for potential targets of ginsenoside compound K
por: Yang, Yuanyuan, et al.
Publicado: (2020)

Gut mucosal microbiota profiles linked to colorectal cancer recurrence
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB Activation
por: Li, Juan, et al.
Publicado: (2014)

A Review of the Effects of Natural Compounds, Medicinal Plants, and Mushrooms on the Gut Microbiota in Colitis and Cancer
por: Cheung, Man Kit, et al.
Publicado: (2020)

Anticancer properties and pharmaceutical applications of ginsenoside compound K: A review
por: Zhou, Li, et al.
Publicado: (2021)

Effects of gut microbiota on the pharmacokinetics of protopanaxadiol ginsenosides Rd, Rg3, F2, and compound K in healthy volunteers treated orally with red ginseng
por: Kim, Jeon-Kyung, et al.
Publicado: (2020)

The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway
por: Zeng, Xiangchang, et al.
Publicado: (2018)

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy
por: Zhang, Jinlan, et al.
Publicado: (2023)

Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation
por: Chen, Zhaoqiang, et al.
Publicado: (2022)

Production of bioactive ginsenoside Rg3(S) and compound K using recombinant Lactococcus lactis
por: Li, Ling, et al.
Publicado: (2018)

Personalized bioconversion of Panax notoginseng saponins mediated by gut microbiota between two different diet-pattern healthy subjects
por: Wang, Li, et al.
Publicado: (2021)

Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis
por: Liu, Jinlong, et al.
Publicado: (2022)

Adhesive ginsenoside compound K patches for cartilage tissue regeneration
por: Yang, Jun-Ho, et al.
Publicado: (2023)

Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2
por: Wang, Yu-Shi, et al.
Publicado: (2019)

Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment
por: Liu, Sheng-Xuan, et al.
Publicado: (2017)

Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
por: Chen, Xu-Jia, et al.
Publicado: (2017)

How Gut Microbiota Are Shaped by Pattern Recognition Receptors in Colitis and Colorectal Cancer
por: Qing, Furong, et al.
Publicado: (2022)

Ginsenoside compound K alleviates osteoarthritis by inhibiting NLRP3‑mediated pyroptosis
por: Li, Yuguo, et al.
Publicado: (2023)

Biotransformation of Ginsenoside Rb(1) to Prosapogenins, Gypenoside XVII, Ginsenoside Rd, Ginsenoside F(2), and Compound K by Leuconostoc mesenteroides DC102
por: Quan, Lin-Hu, et al.
Publicado: (2011)

Canmei Formula Reduces Colitis-Associated Colorectal Carcinogenesis in Mice by Modulating the Composition of Gut Microbiota
por: Zhang, Huayue, et al.
Publicado: (2019)

RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer
por: Zhu, Houbao, et al.
Publicado: (2017)

Helminth-Induced Alterations Of The Gut Microbiota Exacerbate Bacterial Colitis
por: Su, Chienwen, et al.
Publicado: (2017)

Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng
por: Xiao, Jian, et al.
Publicado: (2016)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer
por: Zhu, Wenhan, et al.
Publicado: (2019)

Highly Selective Bioconversion of Ginsenoside Rb1 to Compound K by the Mycelium of Cordyceps sinensis under Optimized Conditions
por: Wang, Wei-Nan, et al.
Publicado: (2015)

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
por: Chen, Yan, et al.
Publicado: (2013)

Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction
por: Zhou, Shan-Shan, et al.
Publicado: (2016)

Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota
por: Li, Junshu, et al.
Publicado: (2023)

Cancer-Preventive Role of Bone Marrow-Derived Mesenchymal Stem Cells on Colitis-Associated Colorectal Cancer: Roles of Gut Microbiota Involved
por: He, Ruohang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8fflmjp7730757q9sk2g69jva